StockData
Inventiva S.A. logo

Inventiva S.A. (IVA) stock

IVANasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as IVEVF
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 8, 2026Score 1/30
$3.39+0.17 (+5.28%)

Close on Nov 18, 2026Market cap $655.07MP/E –Yield –

Inventiva operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

For fiscal 2025 it was -€141.01M. The highest annual figure on record is -€29.72M in fiscal 2020.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-€141.01M–
FY2024Dec 31, 2024-€97.56M–
FY2023Dec 31, 2023-€102.71M–
FY2022Dec 31, 2022-€57.11M–
FY2021Dec 31, 2021-€52.11M–
FY2020Dec 31, 2020-€29.72M–
FY2019Dec 31, 2019-€30.31M–
FY2018Dec 31, 2018-€32.90M–

More Inventiva figures

See a number that looks wrong?